Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-finding trial of Bailing Tongfengxiao granules for acute gouty arthritis
ChiCTR2100044451Phase 2Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Bailing Tongfengxiao Granules in gout and acute gout flare (3 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Percentage change in joint pain VAS score from baseline after treatment on day 5. Started Mar 2021; status: recruiting.
02
Drugs
Bailing Tongfengxiao Granules
03
Conditions
goutacute gout flare
Beyond the preview
Go deeper on ChiCTR2100044451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044451.